Arvinas, Inc. (ARVN)
8.29
-0.02
(-0.24%)
USD |
NASDAQ |
Sep 18, 16:00
8.275
-0.02
(-0.18%)
After-Hours: 20:00
Arvinas Total Long Term Debt (Quarterly) : 6.30M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.30M |
| March 31, 2026 | 6.80M |
| December 31, 2025 | 7.40M |
| September 30, 2025 | 7.80M |
| June 30, 2025 | 8.30M |
| March 31, 2025 | 8.80M |
| December 31, 2024 | 8.10M |
| September 30, 2024 | 0.90M |
| June 30, 2024 | 1.10M |
| March 31, 2024 | 1.30M |
| December 31, 2023 | 1.50M |
| September 30, 2023 | 2.10M |
| June 30, 2023 | 2.60M |
| March 31, 2023 | 3.10M |
| December 31, 2022 | 3.70M |
| September 30, 2022 | 4.10M |
| June 30, 2022 | 4.60M |
| March 31, 2022 | 5.10M |
| December 31, 2021 | 3.90M |
| Date | Value |
|---|---|
| September 30, 2021 | 4.191M |
| June 30, 2021 | 4.397M |
| March 31, 2021 | 5.702M |
| December 31, 2020 | 3.087M |
| September 30, 2020 | 3.352M |
| June 30, 2020 | 3.591M |
| March 31, 2020 | 3.843M |
| December 31, 2019 | 3.714M |
| September 30, 2019 | 3.768M |
| June 30, 2019 | 3.965M |
| March 31, 2019 | 4.250M |
| December 31, 2018 | 2.154M |
| September 30, 2018 | 2.195M |
| June 30, 2018 | 0.234M |
| March 31, 2018 | 0.2726M |
| December 31, 2017 | 0.3104M |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 0.989M |
| CNBX Pharmaceuticals, Inc. | 0.00 |
| GB Sciences, Inc. | -- |
| Fulcrum Therapeutics, Inc. | 2.76M |
| Definium Therapeutics, Inc. | 36.47M |